Using critically ill patients is a good way to show it's not effective. 
The Remap-Cap Covid-19 trial platform is launching a study of ivermectin in critically ill patients in Ireland, France, Pakistan, Nepal, the Netherlands, the US and Canada. (from the Independent, Ireland)pic.twitter.com/npzPwRa2nC
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
This Tweet is unavailable.
-
Yes. I smell yet another designed-to-fail "study".
- Show replies
-
-
-
Critically ill in Western countries -> Use of dexamethasone contra-indicated with ivm (instead of methylprednisolone) -> Trial Designed to fail
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Bad idea but worked great to discredit HCQ
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Would love to feel excited/it is good news but
’s previous experience with clinical trial drugs in the tx of Covid-19 resulted in 1)too restrictive criteria for administration 2)it’s administered too late 3)early intervention with other therapeutics is keyThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
France??
-
#TogetherTrial ?? funded by B & M Gates: Ivemectin, fluvoxamine, colchicine and one more- possibly famotadine.. but not sure. TrialSiteNews spoke of it.
End of conversation
New conversation -
-
-
We need to keep these guys honest. Some of the trials recently are really poor. I hope
@Covid19Critical will get nosey up front about every new trial. I know I will. Same with the Gates funded trials. Don’t want another hatchet job like the sepsis trials. Lesson learned
-
"Together Trial" by Gates?
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.